Vimarsana
Biggest News Aggregation in the World

Page 30 - Initially Neutral News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Initially Neutral. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Initially Neutral Today - Breaking & Trending Today

ASML : Bernstein reaffirms its Neutral rating -December 12, 2023 at 10:22 am EST - Vimarsana News

ASML : Bernstein reaffirms its Neutral rating -December 12, 2023 at 10:22 am EST

Initially Neutral on the company, Bernstein's analyst Mark Li maintained his recommendation. The target price remains set at EUR 630.

Related Topics:
Mark LiInitially Neutral
BEIERSDORF AG : Bernstein gives a Neutral rating -December 12, 2023 at 07:00 am EST - Vimarsana News

BEIERSDORF AG : Bernstein gives a Neutral rating -December 12, 2023 at 07:00 am EST

Initially Neutral on the company, Bernstein's analyst Bruno Monteyne maintained his recommendation. The target price is unchanged and still at EUR 130.

BRITISH AMERICAN TOBACCO : Goldman Sachs sticks Neutral -December 07, 2023 at 02:29 am EST - Vimarsana News

BRITISH AMERICAN TOBACCO : Goldman Sachs sticks Neutral -December 07, 2023 at 02:29 am EST

Initially Neutral on the company, Goldman Sachs's analyst Richard Felton maintained his recommendation. The target price differs slightly and is now set at GBX 2700 versus GBX 2750.

WIZZ AIR : JP Morgan reiterates its Neutral rating -December 07, 2023 at 02:29 am EST - Vimarsana News

WIZZ AIR : JP Morgan reiterates its Neutral rating -December 07, 2023 at 02:29 am EST

Initially Neutral on the company, JP Morgan's analyst Samuel Bland maintained his recommendation. The target price is decreased from GBX 2450 to GBX 2200.

CARL ZEISS MEDITEC AG : Gets a Neutral rating from UBS -December 07, 2023 at 02:38 am EST - Vimarsana News

CARL ZEISS MEDITEC AG : Gets a Neutral rating from UBS -December 07, 2023 at 02:38 am EST

Initially Neutral on the company, UBS's analyst Graham Doyle maintained his recommendation. The target price differs slightly and is now set at EUR 89 versus EUR 87.